Default: Journal of Alzheimer's Disease

ISSN: 1387-2877

Journal Home

Journal Guideline

Journal of Alzheimer's Disease Q1 Unclaimed

IOS Press Netherlands
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Journal of Alzheimer's Disease is a journal indexed in SJR in Medicine (miscellaneous) and Neuroscience (miscellaneous) with an H index of 139. It has an SJR impact factor of 1,677 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,677.

Journal of Alzheimer's Disease focuses its scope in these topics and keywords: alzheimer’s, disease, dementia, cognitive, impairment, mild, amyloid?, risk, patients, frontotemporal, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Metrics

Journal of Alzheimer's Disease

1,677

SJR Impact factor

139

H Index

767

Total Docs (Last Year)

2243

Total Docs (3 years)

42408

Total Refs

10259

Total Cites (3 years)

2230

Citable Docs (3 years)

4,07

Cites/Doc (2 years)

55,29

Ref/Doc

Comments

No comments ... Be the first to comment!

Aims and Scope


alzheimer’s, disease, dementia, cognitive, impairment, mild, amyloid?, risk, patients, frontotemporal, cerebrospinal, imaging, healthy, people, cells, gene, cortex, synaptic, elderly, expression, protein, fluid, pet,



Best articles by citations

Visit-to-Visit Blood Pressure Variability and Alzheimer's Disease: Links and Risks

View more

Genome-Wide Association Study Identifies SLAMF1 Affecting the Rate of Memory Decline

View more

Risk Factors, Neuroanatomical Correlates, and Outcome of Neuropsychiatric Symptoms in Alzheimer's Disease

View more

Blood Genome-Wide Transcriptional Profiles Reflect Broad Molecular Impairments and Strong Blood-Brain Links in Alzheimer's Disease

View more

Time Trends in Antipsychotic Drug Use in Patients with Dementia: A Nationwide Study

View more

Enriching Amnestic Mild Cognitive Impairment Populations for Clinical Trials: Optimal Combination of Biomarkers to Predict Conversion to Dementia

View more

Amyloid-beta/Drug Interactions from Computer Simulations and Cell-Based Assays

View more

Age-Dependent Increment of Hydroxymethylation in the Brain Cortex in the Triple-Transgenic Mouse Model of Alzheimer's Disease

View more

The Effect of Chronic Cerebral Hypoperfusion on Blood-Brain Barrier Permeability in a Transgenic Alzheimer's Disease Mouse Model (PS1V97L)

View more

Altered Neurotransmission Prior to Cognitive Decline in AbetaPP/PS1 Mice, a Model of Alzheimer's Disease

View more

Serum MHPG Strongly Predicts Conversion to Alzheimer's Disease in Behaviorally Characterized Subjects with Down Syndrome

View more

Potential of FTIR Spectroscopy Applied to Exosomes for Alzheimer's Disease Discrimination: A Pilot Study

View more
SHOW MORE ARTICLES

AVN-101: A Multi-Target Drug Candidate for the Treatment of CNS Disorders

View more

Incorporating biomarkers into clinical drug trials in Alzheimer's disease

View more

Improved Risk Stratification for Progression from Mild Cognitive Impairment to Alzheimer's Disease with a Multi-Analytical Evaluation of Amyloid-beta Positron Emission Tomography

View more

Analysis of Salivary Microbiome in Patients with Alzheimer's Disease

View more

Age-Related Alterations in the Metabolic Profile in the Hippocampus of the Senescence-Accelerated Mouse Prone 8: A Spontaneous Alzheimer's Disease Mouse Model

View more

Behavioral and Neuropsychiatric Disorders in Alzheimer's Disease

View more

Albumin-Blunted Deleterious Effect of Amyloid-beta by Preventing the Internalization of the Peptide into Neurons

View more

Alzheimer's Disease Biomarkers and Future Decline in Cognitive Normal Older Adults

View more

Aberrant Co-localization of Synaptic Proteins Promoted by Alzheimer's Disease Amyloid-beta Peptides: Protective Effect of Human Serum Albumin

View more

Association between a-Klotho and Deep White Matter Lesions in the Brain: A Pilot Case Control Study Using Brain MRI

View more

Machine Learning Predictive Models Can Improve Efficacy of Clinical Trials for Alzheimer's Disease

View more

Effect of Experimental Ischemic Stroke and PGE2 EP1 Selective Antagonism in Alzheimer's Disease Mouse Models

View more

FAQS